← FDA DRUG APPROVALS

FDA NDA · NDA020659

NORVIR

Sponsor: ABBVIE

APPLICATION
NDA020659
TYPE
NDA
ORIGINAL APPROVAL
1996-03-01
LATEST ACTION
2022-12-15
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

NORVIR · ReferenceDiscontinued
RITONAVIR 80MG/ML · SOLUTION · ORAL

Approval history

2022-12-15Labeling · Supplement 73 · standardLetterAP
2020-10-21Labeling · Supplement 72 · standardLetterAP
2019-12-19Labeling · Supplement 71 · standardLetterAP
2019-08-21Labeling · Supplement 70 · standardLetterAP
2018-11-15Labeling · Supplement 69 · standardLabelAP
2017-09-29Labeling · Supplement 68 · standardLabelAP
2017-06-29Labeling · Supplement 66 · standardLabelAP
2017-06-07Labeling · Supplement 67 · standardLabelAP
2016-12-22Labeling · Supplement 64 · standardLabelAP
2016-11-22Labeling · Supplement 63 · standardLetterAP
2016-09-15Labeling · Supplement 65 · 901 requiredLetterAP
2015-11-10Labeling · Supplement 62 · standardLetterAP
2015-03-27Labeling · Supplement 61 · 901 requiredLetterAP
2015-03-16Labeling · Supplement 60 · standardLabelAP
2013-11-07Labeling · Supplement 58 · standardLabelAP
2012-11-20Labeling · Supplement 57 · standardLetterAP
2012-02-17Labeling · Supplement 56 · 901 requiredLabelAP
2011-12-06Labeling · Supplement 55 · standardLabelAP
2010-04-27Labeling · Supplement 50 · 901 requiredLabelAP
2010-02-10Labeling · Supplement 45 · standardLabelAP
2009-11-23Labeling · Supplement 47 · standardLetterAP
2008-10-01Labeling · Supplement 43 · standardLetterAP
2008-08-29Labeling · Supplement 42 · standardLabelAP
2008-05-16Labeling · Supplement 39 · standardLetterAP
2007-07-31Labeling · Supplement 40 · standardLabelAP
2007-05-10Labeling · Supplement 36 · standardLabelAP
2005-11-09Labeling · Supplement 33 · standardReviewAP
2005-10-06Efficacy · Supplement 34 · priorityReviewAP
2005-03-28Labeling · Supplement 32 · standardLetterAP
2003-09-10Labeling · Supplement 30 · standardLabelAP
2002-12-24Manufacturing (CMC) · Supplement 28 · priorityAP
2002-03-14Labeling · Supplement 27 · standardLabelAP
2001-08-21Labeling · Supplement 25 · standardLabelAP
2001-03-06Labeling · Supplement 26 · standardLetterAP
2000-09-01Manufacturing (CMC) · Supplement 24 · priorityAP
2000-05-08Labeling · Supplement 23 · standardAP
1999-10-28Manufacturing (CMC) · Supplement 20 · priorityAP
1999-10-26Labeling · Supplement 22 · standardAP
1999-10-21Labeling · Supplement 21 · standardAP
1999-05-26Efficacy · Supplement 13 · standardReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →